Authors: Hla, MM Davis, JW Ross, PD Yates, J Wasnich, RD Ravn, P McClung, M Hosking, D

Citation: Mm. Hla et al., Relation between body composition and biochemical markers of bone turnoveramong early postmenopausal women, J CLIN DENS, 3(4), 2000, pp. 365-371

Authors: Hosking, D

Citation: D. Hosking, Paget's disease, TREATMENT OF METABOLIC BONE DISEASE: MANAGEMENT STRATEGY AND DRUG THERAPY, 2000, pp. 75-95

Authors: Davie, M Davies, M Francis, R Fraser, W Hosking, D Tansley, R

Citation: M. Davie et al., Paget's disease of bone: A review of 889 patients, BONE, 24(5), 1999, pp. 11S-12S

Authors: Buckler, H Fraser, W Hosking, D Ryan, W Maricic, MJ Singer, F Davie, M Fogelman, I Birbara, CA Moses, AM Lyles, K Selby, P Richardson, P Seaman, J Zelenakas, K Siris, E

Citation: H. Buckler et al., Single infusion of zoledronate in Paget's disease of bone: A placebo-controlled, dose-ranging study, BONE, 24(5), 1999, pp. 81S-85S

Authors: Ravn, P Cizza, G Bjarnason, NH Thompson, D Daley, M Wasnich, RD McClung, M Hosking, D Yates, AJ Christiansen, C

Citation: P. Ravn et al., Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women, J BONE MIN, 14(9), 1999, pp. 1622-1627

Authors: Ravn, P Hosking, D Thompson, D Cizza, G Wasnich, RD McClung, M Yates, AJ Bjarnason, NH Christiansen, C

Citation: P. Ravn et al., Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study, J CLIN END, 84(7), 1999, pp. 2363-2368